<?xml version="1.0" encoding="UTF-8"?>
<ref id="B7" class="ref">
 <div publication-type="journal" class="mixed-citation" xmlns="http://www.w3.org/1999/xhtml">
  <person-group person-group-type="author" class="person-group" xmlns="">
   <name class="name">
    <span class="surname" xmlns="http://www.w3.org/1999/xhtml">Choi</span>
    <span class="given-names" xmlns="http://www.w3.org/1999/xhtml">Y. E.</span>
   </name>
   <name class="name">
    <span class="surname" xmlns="http://www.w3.org/1999/xhtml">Yu</span>
    <span class="given-names" xmlns="http://www.w3.org/1999/xhtml">H. N.</span>
   </name>
   <name class="name">
    <span class="surname" xmlns="http://www.w3.org/1999/xhtml">Yoon</span>
    <span class="given-names" xmlns="http://www.w3.org/1999/xhtml">C. H.</span>
   </name>
   <name class="name">
    <span class="surname" xmlns="http://www.w3.org/1999/xhtml">Bae</span>
    <span class="given-names" xmlns="http://www.w3.org/1999/xhtml">Y. S.</span>
   </name>
  </person-group> (
  <span class="year">2009</span>). 
  <div class="article-title">Tumor-mediated down-regulation of MHC class II in DC development is attributable to the epigenetic control of the CIITA type I promoter</div>. 
  <div class="source">Eur. J. Immunol.</div>
  <span class="volume">39</span>, 
  <span class="fpage">858</span>â€“
  <span class="lpage">868</span>
  <span pub-id-type="doi" class="pub-id">10.1002/eji.200838674</span>
  <span pub-id-type="pmid" class="pub-id">19224634</span>
 </div>
</ref>
